Search Results - "Contieri, Roberto"

Neoadjuvant Intravesical Mitomycin C for NMIBC: A Phase III Single-Center, Open-Label Randomized Clinical Trial.

Authors: Contieri, Roberto Saita, Alberto Paciotti, Marco et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1444. 19p.

Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow‐up.

Authors: Contieri, Roberto Martini, Alberto Furrer, Marc et al.

Source: BJU International. Jun2026, Vol. 137 Issue 6, p1058-1066. 9p.

Defining standards for retroperitoneal single‐port (SP) robotic surgery: the Advancing Retroperitoneal International SP Excellence (ARISE) international Delphi consensus.

Authors: Spena, Gianluca Contieri, Roberto Paciotti, Marco et al.

Source: BJU International. May2026, Vol. 137 Issue 5, p895-905. 11p.

Influence of lamina propria invasion extension on T1 high‐grade non‐muscle‐invasive bladder cancer in patients undergoing BCG or radical cystectomy.

Authors: Contieri, Roberto Tan, Wei Shen Grajales, Valentina et al.

Source: BJU International. Jun2024, Vol. 133 Issue 6, p733-741. 9p.

Variation in Follow-Up after Radical Cystectomy for Bladder Cancer—An Inventory Roundtable and Literature Review.

Authors: Contieri, Roberto Pichler, Renate del Giudice, Francesco et al.

Source: Journal of Clinical Medicine. May2024, Vol. 13 Issue 9, p2637. 8p.

Impact of age >70 years on oncological outcomes in patients with non‐muscle‐invasive bladder cancer treated with Bacillus Calmette–Guérin.

Authors: Contieri, Roberto Grajales, Valentina Tan, Wei Shen et al.

Source: BJU International. Jan2024, Vol. 133 Issue 1, p63-70. 8p.

Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients.

Authors: Valeri, Marina Contieri, Roberto Fasulo, Vittorio et al.

Source: Cancers. Feb2023, Vol. 15 Issue 3, p934. 11p.

Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. 2026;89:437–445

Authors: Contieri, Roberto Lazzeri, Massimo Perdonà, Sisto et al.

Source: European Urology. Jul2026, Vol. 90 Issue 1, pe13-e14. 2p.

Inflammatory markers and Type 2 diabetes mellitus as prognostic risk factors in low‐risk bladder cancer.

Authors: Frego, Nicola Contieri, Roberto Diana, Pietro et al.

Source: BJU International. Aug2023, Vol. 132 Issue 2, p154-156. 3p.

Comment to "Targeting tumour surface collage with hydrogel probe: a new strategy to enhance intraoperative imaging sensitivity and stability of bladder cancer".

Authors: Contieri, Roberto Uleri, Alessandro Hurle, Rodolfo et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2024, Vol. 51 Issue 13, p4177-4178. 2p.

The role of primary tumour site surgery in metastatic UTUC: a systematic review and meta‐analysis.

Authors: Cella, Ludovica Moretto, Stefano Contieri, Roberto et al.

Source: BJU International. Oct2025, Vol. 136 Issue 4, p602-611. 10p.

Assessing risk stratification in Bacillus Calmette–Guérin–treated high-grade Ta nonmuscle-invasive bladder cancer patients.

Authors: Finocchiaro, Alessio Contieri, Roberto Piccolini, Andrea et al.

Source: Urologic Oncology. Feb2026, Vol. 44 Issue 2, p111-111. 1p.

Refining BCG‐failure classifications in non‐muscle‐invasive bladder cancer.

Authors: Ślusarczyk, Aleksander Scilipoti, Pietro Contieri, Roberto et al.

Source: BJU International. Jun2026, Vol. 137 Issue 6, p1076-1087. 12p.

Assessing oncological outcomes of bladder-sparing treatments in patients with BCG-unresponsive and BCG-exposed non-muscle-invasive bladder cancer.

Authors: Piccolini, Andrea Contieri, Roberto Uleri, Alessandro et al.

Source: Urologic Oncology. Nov2025, Vol. 43 Issue 11, p666-666. 1p.

Staging Accuracy and Prognostic Value of Prostate-Specific Membrane Antigen PET/CT Strongly Depends on Lymph Node Tumor Burden.

Authors: Özman, Oktay Veerman, Hans Contieri, Roberto et al.

Source: Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 21, p6534. 9p.

Comment to: "Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer".

Authors: Hurle, Rodolfo Contieri, Roberto Lazzeri, Massimo

Source: World Journal of Urology. 2/10/2025, Vol. 43 Issue 1, p1-2. 2p.

Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy.

Authors: Zattoni, Fabio Mari, Andrea Falagario, Ugo Giovanni et al.

Source: Diagnostics (2075-4418). May2026, Vol. 16 Issue 9, p1310. 19p.

Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy.

Authors: Contieri, Roberto Claps, Francesco Hurle, Rodolfo et al.

Source: Urologic Oncology. Mar2025, Vol. 43 Issue 3, p118-118. 1p.

Impact of 3D Virtual Modeling on Perioperative Outcomes in Robot-Assisted Partial Nephrectomy.

Authors: Passaro, Francesco Aveta, Achille Spena, Gianluca et al.

Source: Diagnostics (2075-4418). Apr2026, Vol. 16 Issue 7, p1082. 12p.

Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?

Authors: Finocchiaro, Alessio Paciotti, Marco Contieri, Roberto et al.

Source: BJU International. Aug2024, Vol. 134 Issue 2, p195-197. 3p.